Related Experiment Video
Updated: Jul 22, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Delayed-interval delivery in multiple gestation pregnancies: neonatal mortality, morbidity, and development.
Nicolas J Bouey1, Shampa Saha2, Deanne E Wilson-Costello3,4
1Case Western Reserve University School of Medicine, Cleveland, OH, USA. Nicolas.Bouey@case.edu.
Delayed-interval delivery (DID) for multiple gestation pregnancies showed no harm to infants. This method may decrease bronchopulmonary dysplasia, potentially due to increased gestational age and birthweight in retained infants.
Area of Science:
- Perinatology
- Neonatology
- Maternal-Fetal Medicine
Background:
- Delayed-interval delivery (DID) involves delivering the first fetus in a multiple gestation pregnancy while delaying the delivery of the remaining fetus(es).
- Assessing infant outcomes associated with DID is crucial for understanding its safety and efficacy.
Purpose of the Study:
- To evaluate infant outcomes in multiple gestation pregnancies undergoing delayed-interval delivery (DID).
- To compare mortality, morbidity, and developmental outcomes of infants born via DID with other multiple births.
Main Methods:
- Retrospective cohort study including infants born between 22-28 weeks' gestation or weighing 401-1500g.
- DID defined as >24 hours between the birth of the firstborn and retained infant.
- Comparison of outcomes within DID multiples, non-DID multiples, and the general infant population.
Main Results:
- Infants born via DID were younger and smaller compared to other multiples.
- Retained infants in DID did not show significantly different mortality or morbidity rates compared to their firstborn counterparts.
- A notable finding was a lower rate of bronchopulmonary dysplasia in retained infants.
Conclusions:
- Delayed-interval delivery (DID) demonstrates no evidence of harm in multiple gestation pregnancies.
- DID may offer a potential benefit, including a reduction in bronchopulmonary dysplasia.
- This benefit may be mediated by increased gestational age and birthweight in infants born via DID.
More Related Videos
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
09:31Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Related Concept Videos
Teratogenicity
Intrauterine Drug Delivery Systems
Development of the Oral Microbiota